Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2

N. E. Kay, M. M. Oken, J. J. Mazza, E. C. Bradley, J. H. Glick, P. Wiernik, J. M. Bennett, J. Kirkwood

Research output: Contribution to journalArticle

20 Scopus citations

Fingerprint Dive into the research topics of 'Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2'. Together they form a unique fingerprint.